Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001349
Filing Date
2025-05-15
Accepted
2025-05-15 17:22:51
Documents
57
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20250331x10q.htm   iXBRL 10-Q 1144551
2 EX-31.1 tmb-20250331xex31d1.htm EX-31.1 12948
3 EX-31.2 tmb-20250331xex31d2.htm EX-31.2 12841
4 EX-32 tmb-20250331xex32.htm EX-32 9829
  Complete submission text file 0001410578-25-001349.txt   5428675

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20250331.xsd EX-101.SCH 46877
6 EX-101.CAL tmb-20250331_cal.xml EX-101.CAL 51400
7 EX-101.DEF tmb-20250331_def.xml EX-101.DEF 195202
8 EX-101.LAB tmb-20250331_lab.xml EX-101.LAB 426793
9 EX-101.PRE tmb-20250331_pre.xml EX-101.PRE 308689
60 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20250331x10q_htm.xml XML 747465
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39752 | Film No.: 25955895
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)